These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9410658)

  • 41. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
    Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
    Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nursing challenges caring for bone marrow transplantation patients with graft versus host disease.
    Neumann J
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):192-194. PubMed ID: 28683255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathology of bone marrow transplantation.
    Bombi JA; Palou J; Bruguera M; Feliu E; Martin-Ortega E; Rozman C; Cardesa A
    Semin Diagn Pathol; 1992 Aug; 9(3):220-31. PubMed ID: 1523360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence.
    Woltz P; Castro K; Park BJ
    Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of skin biopsies in bone marrow transplant recipients.
    Hepburn NC; McLaren KM; Turner ML; Beveridge GW
    Q J Med; 1993 Nov; 86(11):715-7. PubMed ID: 8265771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psoriasiform eruption associated with graft-versus-host disease.
    Taguchi S; Kawachi Y; Fujisawa Y; Nakamura Y; Furuta J; Otsuka F
    Cutis; 2013 Sep; 92(3):151-3. PubMed ID: 24153145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncology nurses' knowledge of graft-versus-host disease in bone marrow transplant patients.
    Copel LC; Smith ME
    Cancer Nurs; 1989 Aug; 12(4):243-9. PubMed ID: 2670199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Squamous cell carcinoma of the sole in a patient with chronic graft-vs-host disease.
    Howe NR; Lang PG
    Arch Dermatol; 1988 Aug; 124(8):1244-5. PubMed ID: 3401029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous graft-versus-host disease: rationales and treatment options.
    Chavan R; el-Azhary R
    Dermatol Ther; 2011; 24(2):219-28. PubMed ID: 21410611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic management of graft-versus-host disease (GVHD).
    Matsumoto Y; Akama Y; Tase C; Okuaki A
    Fukushima J Med Sci; 1993 Dec; 39(2):117-9. PubMed ID: 7927135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and management of chronic graft-versus-host disease.
    Dignan FL; Amrolia P; Clark A; Cornish J; Jackson G; Mahendra P; Scarisbrick JJ; Taylor PC; Shaw BE; Potter MN; ;
    Br J Haematol; 2012 Jul; 158(1):46-61. PubMed ID: 22533811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mucocutaneous and salivary manifestations of the graft vs host reaction after bone marrow transplantation].
    d'Agay MF; Brocheriou C; Kuffer R; Gluckman E; Janin A; Saurat JH
    Rev Stomatol Chir Maxillofac; 1984; 85(5):370-4. PubMed ID: 6393313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Organ-specific management and supportive care in chronic graft-versus-host disease.
    Dignan FL; Scarisbrick JJ; Cornish J; Clark A; Amrolia P; Jackson G; Mahendra P; Taylor PC; Shah P; Lightman S; Fortune F; Kibbler C; Andreyev J; Albanese A; Hadzic N; Potter MN; Shaw BE; ;
    Br J Haematol; 2012 Jul; 158(1):62-78. PubMed ID: 22533889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cutaneous manifestations of graft versus host disease in a population of pediatric and young adults patients].
    Martino C; Calvano R; Boggio P; Scacchi MF; Sojo M; Carbajosa A; Makiya M; Giachetti A
    Arch Argent Pediatr; 2020 Oct; 118(5):e468-e475. PubMed ID: 32924403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The skin manifestation of acute graft-versus-host disease: clinical and pathological analysis.
    Hsu ML; Chen YC; Wu YC; Chen CL; Yeh HP; Hsieh KH; Lu YC
    Taiwan Yi Xue Hui Za Zhi; 1989 Jul; 88(7):657-62. PubMed ID: 2809558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service.
    de Vere Hunt I; Kilgour JM; Danby R; Peniket A; Matin RN
    Health Qual Life Outcomes; 2021 Jan; 19(1):11. PubMed ID: 33413414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dyskeratosis congenita in a girl simulating chronic graft-vs-host disease.
    Ling NS; Fenske NA; Julius RL; Espinoza CG; Drake LA
    Arch Dermatol; 1985 Nov; 121(11):1424-8. PubMed ID: 3901930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutaneous manifestations of chronic graft-versus-host disease.
    Andrews ML; Robertson I; Weedon D
    Australas J Dermatol; 1997 May; 38(2):53-62; quiz 63-4. PubMed ID: 9159958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.